Quality & complianceOfficial

SÚKL says no Comirnaty batch inspected or vaccine withdrawn after 2020–2026 pharmacovigilance signals

🇨🇿 SÚKL · Wed 18 Nov 2026

Replying to a freedom-of-information request, the Czech regulator explains how it assesses causality, handles recalls and positions national reference laboratories, and reports no new batch-related risk for Comirnaty.

SÚKL, the Czech State Institute for Drug Control, has published its partial response to a freedom-of-information request dated 18 July 2026 on the Comirnaty vaccine and the Institute's cooperation with external bodies. The reply was posted on 18 November 2026 by its legal affairs department.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: SÚKL ↗

Article written by VigiEye from the official source (SÚKL). AI-assisted; check the source before acting.